These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 25903652

  • 1. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y, Hu XF, Wang Y, Chen HY, Yang L, Liu LZ, Cui CY, Liu DS, Liang SB.
    BMC Cancer; 2015 Apr 18; 15():305. PubMed ID: 25903652
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.
    Liang SB, Deng YM, Zhang N, Lu RL, Zhao H, Chen HY, Li SE, Liu DS, Chen Y.
    BMC Cancer; 2013 May 27; 13():260. PubMed ID: 23710879
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX, Wang Y, Cao PF, Shen L, Zhao YJ, Zhang ZJ, Chen DM, Yang TB, Huang XQ, Qin Z, Dai YY, Shen LF.
    Chin J Cancer; 2016 Nov 16; 35(1):96. PubMed ID: 27852284
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liang SB, Teng JJ, Hu XF, Yang XL, Luo M, Fang XN, Liu DS, Chen Y, Fu LW.
    BMC Cancer; 2017 Jul 28; 17(1):506. PubMed ID: 28754109
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y, Pan J, Chen Y, Lin S, Chen Y, Zong J, Fang Y, Guo Q, Chen B, Tang L.
    Radiat Oncol; 2015 Sep 25; 10():204. PubMed ID: 26407897
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
    Chen YP, Tang LL, Zhang WN, Mao YP, Chen L, Sun Y, Liu LZ, Li WF, Liu X, Zhou GQ, Guo R, Mai HQ, Shao JY, Lin AH, Li L, Ma J.
    Medicine (Baltimore); 2015 Oct 25; 94(43):e1624. PubMed ID: 26512556
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL, Wang Y, Liang SB, He SS, Chen DM, Chen HY, Lu LX, Chen Y.
    BMC Cancer; 2018 May 29; 18(1):606. PubMed ID: 29843648
    [Abstract] [Full Text] [Related]

  • 8. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
    Guo R, Sun Y, Yu XL, Yin WJ, Li WF, Chen YY, Mao YP, Liu LZ, Li L, Lin AH, Ma J.
    Radiother Oncol; 2012 Sep 29; 104(3):294-9. PubMed ID: 22998947
    [Abstract] [Full Text] [Related]

  • 9. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY.
    Eur J Cancer; 2015 Nov 29; 51(17):2587-95. PubMed ID: 26318726
    [Abstract] [Full Text] [Related]

  • 10. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y, Qin Y, Lang J.
    Clin Transl Oncol; 2017 Apr 29; 19(4):470-476. PubMed ID: 27718153
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.
    Zhou GQ, Mao YP, Chen L, Li WF, Liu LZ, Sun Y, Chen Y, Tian L, Lin AH, Li L, Ma J.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1090-7. PubMed ID: 21864993
    [Abstract] [Full Text] [Related]

  • 12. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma.
    Liang SB, Chen LS, Yang XL, Chen DM, Wang DH, Cui CY, Xie CB, Liu LZ, Xu XY.
    Radiother Oncol; 2021 Feb 01; 155():219-225. PubMed ID: 33217495
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
    Liao JF, Ma L, Du XJ, Lan M, Guo Y, Zheng L, Xia YF, Luo W.
    PLoS One; 2016 Feb 01; 11(1):e0146787. PubMed ID: 26824230
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
    Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, Deng X, Huang S, Lin C, Lu T.
    Radiother Oncol; 2014 Mar 01; 110(3):398-403. PubMed ID: 24231245
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X, Zhou X, Shi Q, Xing X, Yang Y, Xu T, Shen C, Wang X, He X, Kong L, Ying H, Hu C.
    Oncotarget; 2015 Nov 10; 6(35):38381-97. PubMed ID: 26485757
    [Abstract] [Full Text] [Related]

  • 16. Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?
    Zong J, Lin S, Chen Y, Wang B, Xiao Y, Lin J, Li R, Pan J.
    PLoS One; 2014 Nov 10; 9(6):e100571. PubMed ID: 24963626
    [Abstract] [Full Text] [Related]

  • 17. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J, Lin S, Lin J, Tang L, Chen B, Zhang M, Zhang Y, Xu L, Chen Y, Xiao Y, Fang Y, Pan J.
    Oral Oncol; 2015 Mar 10; 51(3):254-9. PubMed ID: 25467207
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
    Liang SB, Zhang N, Chen DM, Yang XL, Chen BH, Zhao H, Lu RL, Chen Y, Fu LW.
    Radiother Oncol; 2019 Mar 10; 132():223-229. PubMed ID: 30366725
    [Abstract] [Full Text] [Related]

  • 19. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Feng M, Wang W, Fan Z, Fu B, Li J, Zhang S, Lang J.
    Radiat Oncol; 2013 Sep 05; 8():208. PubMed ID: 24007375
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.